FURTHER STUDIES IN TREATMENT OF FEMALE AND MALE TRICHOMONIASIS WITH METRONIDAZOLE.
D000981:Antiprotozoal Agents; D002181:Candidiasis, Vulvovaginal; D002353:Carrier State; D003141:Communicable Diseases; D004813:Epidemiology; D005260:Female; D005333:Fetus; D006801:Humans; D007093:Imidazoles; D008297:Male; D008795:Metronidazole; D011247:Pregnancy; D011248:Pregnancy Complications; D011251:Pregnancy Complications, Infectious; D012661:Semen; D013094:Spermatozoa; D013223:Statistics as Topic; D013607:Tablets; D014116:Toxicology; D014244:Trichomonas; D014245:Trichomonas Infections; D014247:Trichomonas Vaginitis
D000981:Antiprotozoal Agents; D007093:Imidazoles; D013607:Tablets; D008795:Metronidazole
ANTIPROTOZOAL AGENTS; CARRIER STATE; EPIDEMIOLOGY; FETUS; IMIDAZOLES; MONILIASIS, VULVOVAGINAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEMEN; SPERMATOZOA; STATISTICS; TABLETS; TOXICOLOGIC REPORT; TRICHOMONAS INFECTIONS; TRICHOMONAS PROSTATO- SEMINO-VESICULITIS; TRICHOMONAS VAGINITIS